Coronavirus (COVID-19)HealthLifestyle

FDA Authorizes the First Breath Test to Detect COVID-19

On August 14, 2022, the Federal Drug Administration (FDA) authorized the first breath test for COVID-19. The authorization is an important milestone for the current pandemic as testing methods continue to evolve. With a simple exhale, individuals could test positive for COVID in just three minutes. While a PCR test needs to confirm their case, the breath test is a powerful screening tool that could support better management of the current pandemic.

The breath test could also cater to testing for other illnesses, helping to combat future potential outbreaks. Rapid screening can help ensure patients receive an accurate diagnosis and treatment as soon as possible. It can also help states identify potential surges and take protective actions accordingly.

InspectIR Systems Creates COVID-19 Breath Test

Read More »

Related Articles

Back to top button


Get a daily email of trending news and updates. Be the first to see top stories and events.